The predictive value of lncRNA MIR31HG expression on clinical outcomes in patients with solid malignant tumors.

Tu, Chao; Ren, Xiaolei; He, Jieyu; Li, Shuangqing; Qi, Lin; Duan, Zhixi; Wang, Wanchun; Li, Zhihong

Tu, Chao; Ren, Xiaolei; He, Jieyu; Li, Shuangqing; Qi, Lin; Duan, Zhixi; Wang, Wanchun; Li, Zhihong.

Afiliação

Tu C; 1Department of Orthopedics, The Second Xiangya Hospital, Central South University, No 139 Middle Renmin Road, Changsha, Hunan 410011 China.
Ren X; 2Hunan Key Laboratory of Tumor Models and Individualized Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011 China.
He J; 1Department of Orthopedics, The Second Xiangya Hospital, Central South University, No 139 Middle Renmin Road, Changsha, Hunan 410011 China.
Li S; 2Hunan Key Laboratory of Tumor Models and Individualized Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011 China.
Qi L; 3Department of Geriatrics, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011 China.
Duan Z; 1Department of Orthopedics, The Second Xiangya Hospital, Central South University, No 139 Middle Renmin Road, Changsha, Hunan 410011 China.
Wang W; 2Hunan Key Laboratory of Tumor Models and Individualized Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011 China.
Li Z; 1Department of Orthopedics, The Second Xiangya Hospital, Central South University, No 139 Middle Renmin Road, Changsha, Hunan 410011 China.

Cancer Cell Int ; 20: 115, 2020.

Article em En | MEDLINE | ID: mdl-32280307

Palavras-chave

LncRNA MIR31HG,; Overall survival; Prognosis; Sarcoma; Tumor

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google